title: Serum amino acids, liver status, and antiepileptic drug therapy in epilepsy.
abstract: Serum amino acid (AA) profiles are altered in epilepsy. It is not clear whether this is due to the disease process itself or to other variables such as seizure type, seizure frequency, duration of illness, medication, or altered liver function. We investigated serum AA profiles and liver enzymes in 73 epileptic patients and 90 healthy subjects and evaluated the data by analysis of variance to discriminate between age, sex, seizure type, duration of illness, seizure frequency, antiepileptic drug (AED) and increased serum liver enzyme levels, and their putative interaction with the serum AA profile. There was no correlation between the changes in the AA profile and age, duration of illness, seizure frequency, and seizure type. Seventy-two percent of the AED-treated patients and 33% of the unmedicated patients showed an increase in one or several serum liver enzymes [alanine aminotransferase (ALT), aspartate aminotransferase (AST), and/or gamma-glutamyl transferase (gamma-GT)]; particularly gamma-GT. We observed a significant increase in serum concentrations of glutamine and glycine and decreased levels of taurine, threonine, serine, valine, methionine, isoleucine, leucine, phenylalanine, histidine, tryptophan, and arginine in AED-treated patients but not in unmedicated patients. These results show that the changes in the serum AA profiles of epileptic patients treated with AEDs occur in patients with alteration of serum liver enzymes; whether this implies a causal relation is still uncertain.
authors.affiliation: Nervenklinik der Rheinischen Friedrich-Wilhelms-Universität, Bonn, Germany.
authors.forename: M L
authors.initials: ML
authors.lastname: Rao
authors.forename: H
authors.initials: H
authors.lastname: Stefan
authors.forename: C
authors.initials: C
authors.lastname: Scheid
authors.forename: A D
authors.initials: AD
authors.lastname: Kuttler
authors.forename: W
authors.initials: W
authors.lastname: Fröscher
mesh_terms: D000328:Adult; D000367:Age Factors; D000410:Alanine Transaminase / Q000145:classification; D000596:Amino Acids / Q000097:blood*; D000927:Anticonvulsants / Q000627:therapeutic use*; D001219:Aspartate Aminotransferases / Q000097:blood; D002220:Carbamazepine / Q000627:therapeutic use; D004827:Epilepsy / Q000097:blood* / Q000188:drug therapy / Q000201:enzymology; D005260:Female; D006801:Humans; D008099:Liver / Q000201:enzymology*; D008297:Male; D012720:Severity of Illness Index; D014635:Valproic Acid / Q000627:therapeutic use; D005723:gamma-Glutamyltransferase / Q000097:blood
chemical_list: D000596:Amino Acids; D000927:Anticonvulsants; D002220:Carbamazepine; D014635:Valproic Acid; D005723:gamma-Glutamyltransferase; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase